Profitability Insights from Sido Muncul: A Five-Year Financial Analysis
DOI:
https://doi.org/10.65310/f34byj96Kata Kunci:
Financial Performance, Financial Ratios, Profitability, Return on Assets, Sido Muncul.Abstrak
This study examined the profitability dynamics of PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) over 2021–2025, focusing on differences between revenue growth and earnings performance. A descriptive quantitative design was employed using secondary data from the company's annual financial statements. Profitability was assessed through Gross Profit Margin (GPM), Net Profit Margin (NPM), Return on Assets (ROA), and Return on Equity (ROE), with annual comparisons against the reference benchmarks specified in the study. The results revealed declining profitability during 2022–2023 followed by recovery in 2024–2025. Average GPM reached 57.20%, consistently exceeding the 30% benchmark, while average NPM was 29.34%, remaining above the 20% benchmark throughout the period. Average ROA was 29.12%, with annual values exceeding the 30% reference only in 2021 and 2025. Average ROE reached 33.78%, rising to a five-year high of 39.4% in 2025. Despite sales exceeding their 2021 level in 2025, net profit and NPM remained lower than their initial values. These differences indicate that improvements in revenue, margins, and resource-based returns did not progress uniformly. The findings support multidimensional profitability assessment while providing descriptive evidence for broader financial performance evaluation and further analysis of earnings efficiency across changing business conditions in Indonesia's pharmaceutical manufacturing sector.
Unduhan
Referensi
Agustin, O., Anwar, Y., & Bramana, S. M. (2023). Analisis rasio profitabilitas terhadap optimalisasi laba pada PT Grand Titian Residence. Jurnal Media Wahana Ekonomika, 20(1), 202–215. https://jurnal.univpgri-palembang.ac.id/index.php/Ekonomika/article/view/9395
Alvian, L., Wardiyah, N. A., Putri, S. E., Apriliyani, D. R., & Herayati, H. (2026). Analisis rasio keuangan untuk menilai kinerja keuangan pada PT Industri Jamu & Farmasi Sido Muncul Tbk periode 2020–2024. Simpati, 4(2), 238–254. https://doi.org/10.59024/simpati.v4i2.2065
Buntu, B. (2023). Analisis rasio likuiditas, rasio leverage dan profitabilitas pada PT Telkom Indonesia (Persero) Tbk. Jurnal Ekonomi dan Bisnis, 15(1), 1–14. https://doi.org/10.55049/jeb.v15i1.142
Dwiningsih, S., Sanusi, A., & Subiyantoro, E. (2024). Profitability analysis of Indonesian pharmaceutical manufacturing companies: Capital structure and company size. Innovation Business Management and Accounting Journal, 3(2), 248–254. https://doi.org/10.56070/ibmaj.2024.026
Faisal, A., Samben, R., & Pattisahusiwa, S. (2017). Analisis kinerja keuangan. KINERJA, 14(1), 6–15. https://doi.org/10.29264/jkin.v14i1.2444
Fernald, K. D. S., Förster, P. C., Claassen, E., & van de Burgwal, L. H. M. (2024). The pharmaceutical productivity gap: Incremental decline in R&D efficiency despite transient improvements. Drug Discovery Today, 29(11), Article 104160. https://doi.org/10.1016/j.drudis.2024.104160
Hafitriyanti, R. A., Syahrudin, M., & Pawitri, W. (2025). Profitability and capital structure as determinants of firm value: An empirical study in the pharmaceutical industry. Jurnal Audit, Pajak, Akuntansi Publik (AJIB), 4(1), 59–67. https://doi.org/10.32897/ajib.2025.4.1.4707
Hermawan, W. D., Ishak, G., & Budiantoro, A. (2023). The impact of financial ratios on return on asset, moderated by total assets: A study on pharmaceutical companies in Indonesia. European Journal of Business and Management Research, 8(4). https://doi.org/10.24018/ejbmr.2023.8.4.2003
Ikatan Akuntan Indonesia. (2016). Standar Akuntansi Keuangan Entitas Mikro, Kecil, Dan Menengah (SAK EMKM). https://iaiglobal.or.id/v03/files/file_sak/emkm/
Kasmir. (2015). Analisis Laporan Keuangan. Rajawali. Jakarta.
Kasmir. (2016). Analisis Laporan Keuangan (Edisi revisi). Rajawali Pers.
Kharisma, A. (2025). Financial ratio analysis at PT Phapros Tbk. International Journal Management and Economic, 4(1), 22–32. https://doi.org/10.56127/ijme.v4i1.1910
Kholiza, C. N., Hasanah, S. R., & Amani, T. (2025). The effect of liquidity and profitability on stock prices of pharmaceutical companies listed on the IDX period 2021–2024. ACCOUNTABLE: International Journal of Accounting, Finance and Tax Research, 1(2). https://doi.org/10.51747/ajfe4v45
Kumalasari, F., Munawarah, & Parluhutan, T. A. (2023). Analisis kinerja keuangan perusahaan di sektor kesehatan yang terdaftar di Bursa Efek Indonesia. Jurnal Ilmiah Manajemen dan Bisnis (JIMBI), 4(1), 21–29. https://doi.org/10.31289/jimbi.v4i1.1682
Ladjar, T. T., & Swasti, H. S. (2024). Analysis of liquidity ratio, profitability, and solvability to evaluate the performance of pharmaceutical companies listed on Indonesia Stock Exchange (BEI) during the period 2021–2023. International Conference on Economics, Business, and Management Research (ICEBMR), 3(1), 457–471. https://doi.org/10.24071/icebmr.v3i1.120
Maitri Ratana, M. (2024). Analysis of financial ratios of PT Industri Jamu and Farmasi Sido Muncul TBK (Sido) for the period of 2018–2020. Jurnal Indonesia Sosial Teknologi, 5(7), 3361–3372. https://doi.org/10.59141/jist.v5i7.1237
Martiana, Y., Wgini, W., & Hidayah, N. R. (2022). Analisis rasio profitabilitas untuk menilai kinerja keuangan pada PT Kimia Farma (Persero) Tbk. EKOMBIS REVIEW: Jurnal Ilmiah Ekonomi dan Bisnis, 10(1), 67–75. https://doi.org/10.37676/ekombis.v10i1
Maulida, F., & Yuliyanto, W. (2026). Analisis kinerja keuangan PT. Industri Jamu dan Farmasi Sido Muncul Tbk terhadap rata-rata industri farmasi tahun 2023–2024. JASABE, 2(1), 65–81. https://doi.org/10.37339/jasabe.v2i1.2682
Melyantika, Endrekson, R., & Harahap, Z. (2025). Analisis rasio likuiditas dan rasio profitabilitas untuk menilai kinerja keuangan pada PT Industri Jamu dan Farmasi Sido Muncul Tbk. tahun 2021–2023. Jurnal Ekonomi Manajemen dan Bisnis (JEMB), 3(1), 200–205. https://doi.org/10.62017/jemb.v3i1.5732
Movizar, R., & Ningrum, D. (2026). Analisis kinerja keuangan berdasarkan rasio likuiditas dan profitabilitas pada PT Industri Jamu dan Farmasi Sido Muncul Tbk. INVESTASI: Inovasi Jurnal Ekonomi dan Akuntansi, 4(2), 164–174. https://doi.org/10.59696/investasi.v4i2.268
Murtadho, M. N., & Wahyudi, H. D. (2026). Financial performance analysis of PT Industri Jamu dan Farmasi Sido Muncul Tbk based on financial ratios for the period 2021–2025. Inovasi Pembangunan: Jurnal Kelitbangan, 14(1). https://doi.org/10.35450/jip.v14i1.1749
PT Industri Jamu dan Farmasi Sido Muncul Tbk. (2021). Annual report 2021.
PT Industri Jamu dan Farmasi Sido Muncul Tbk. (2022). Annual report 2022.
PT Industri Jamu dan Farmasi Sido Muncul Tbk. (2023). Annual report 2023.
PT Industri Jamu dan Farmasi Sido Muncul Tbk. (2024). Annual report 2024.
PT Industri Jamu dan Farmasi Sido Muncul Tbk. (2025). Annual report 2025.
Pudjianto, V. C., Widagdo, B., & Kholmi, M. (2024). Assessing the relationship between financial ratios, dividend policy, and stock prices in Indonesia’s pharmaceutical industry. Business Innovation Management and Entrepreneurship Journal, 3(2), 78–92. https://doi.org/10.22219/bimantara.v3i02.32003
Rahim, D. A., Citarayani, I., & Marbun, M. C. (2025). Linking financial performance to profit growth: Empirical insights from pharmaceutical firms in Indonesia. E-Jurnal Akuntansi, 35(6), 1772–1787. https://doi.org/10.24843/EJA.2025.v35.i06.p18
Rahmawati, R., Herlinawati, E., & Suryaningprang, A. (2025). The effect of current ratio, debt to asset ratio, and debt to equity ratio on return on assets in pharmaceutical companies on the Indonesian Stock Exchange, period 2015–2024. International Journal Administration, Business & Organization, 6(3), 411–427. https://doi.org/10.61242/ijabo.25.667
Romli, Z. M., & Akhmadi. (2024). The influence of financial performance and capital structure on firm value in pharmaceutical companies registered on the IDX 2019–2023 with company size as variable moderation. International Journal of Social Science and Human Research, 7(6). https://doi.org/10.47191/ijsshr/v7-i06-111
Rosita, Y. (2024). Net profit margin as driver of firm value: A study of the pharmaceutical sector listed on IDX. Golden Ratio of Data in Summary, 4(1), 196–204. https://doi.org/10.52970/grdis.v4i1.1080
Safitri, N. A., & Yuningsih, Y. Y. (2024). The influence of working capital and sales growth on net profit at PT Sido Muncul Tbk (case study on the Indonesian Stock Exchange for the 2018–2023 period). Formosa Journal of Social Sciences, 3(2), 265–286. https://doi.org/10.55927/fjss.v3i2.10040
Shofwatun, H., Kosasih, K., & Megawati, L. (2021). Analisis kinerja keuangan berdasarkan rasio likuiditas dan rasio profitabilitas pada PT Pos Indonesia (Persero). KRISNA: Kumpulan Riset Akuntansi, 13(1), 59–74. https://doi.org/10.22225/kr.13.1.2021.59-74
Subardi, A., & Arta, G. (2019). Analisis rasio profitabilitas pada PT Bank Permata Tbk. JBEE: Journal Business Economics and Entrepreneurship, 1(2), 1–8. http://jurnal.shantibhuana.ac.id/jurnal/index.php/bee
Sukmawati, V. D., Soviana, H., Ariyantina, B., & Citradewi, A. (2022). Kinerja keuangan ditinjau dari analisis rasio profitabilitas (studi pada PT Erajaya Swasembada periode 2018–2021). Jurnal Ilmiah Akuntansi dan Bisnis, 7(2), 189–206. https://doi.org/10.38043/jiab.v7i2.3692
Syafii, M., Ariadi, W., & Rerung, A. (2022). Analisis rasio profitabilitas dalam mengukur pertumbuhan laba usaha PT Astra International Tbk. Jurnal Ekonomi dan Bisnis, 14(2), 1–14. https://doi.org/10.55049/jeb.v14i1.119
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Valentine Clara Valerie, Novia Setyo Ambarwanti, Indy Era Basyira, Risky Budianto (Author)
Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
